AGING CELL 润色咨询

AGING CELL

出版年份:2002 年文章数:2087 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:3.6% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=591350, encodeId=6cee591350b9, content=请问显示under review约一周后后变成了with supervising editor正常么 <br> 艾特 188****3191(暂无昵称), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd861997355, createdName=aipanda皮, createdTime=Wed May 20 23:08:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970070, encodeId=9d349e007046, content=投稿命中率:25.0<br>偏重的研究方向:细胞衰老<br>经验分享:投了一篇,7张大图,纯细胞研究。一审一个半月,4个审稿人,一堆问题,还需要补实验。修改用了三个月,中间还申请了一次延迟,补了不少实验。修回去之后,二审两个礼拜,直接接收。总体很nice,是一本非常认真的期刊,审稿人水平很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Tue Jun 01 14:36:26 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248213, encodeId=46f912482132d, content=7.1 投稿 <br>7.2-7.24 with editor in chief <br>7.25-8.4 under review <br>8.5-8.19 with supervising editor <br>8.20-9.5 under review <br>9.6-9.7 with supervising editor <br>9.8-至今 In review <br>已经两个多月了 ,想请教投过这个期刊上岸的大神,这后边还有什么步骤大概多久才能回来一审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=ms4000000851485808, createdTime=Fri Sep 09 21:44:11 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223567, encodeId=1624122356e85, content=偏重的研究方向:骨骼衰老<br>经验分享:投稿已经一周了,一直with editor in chief ,大家遇到过这种情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKHJoeMDwT8ic73jBc5wUdyQXpogRZA8D2ibh5gOicQ2Vs2xrKjGAdxic8jNfnNICEXZuUNeapibUJooNg/0, createdBy=76982150486, createdName=术士话剧, createdTime=Tue May 31 11:14:53 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147495, encodeId=4453214e49507, content=投稿命中率:25.0<br>经验分享:2022/10/31 投稿<br>2022/11/4 With supervising editor<br>2022/11/5 Under review<br>2022/11/14 In Review<br>2022/12/1 Decision:Major revision<br><br>2023/5/8 Revision submitted<br>2023/6/5 Decision: Minor revision<br><br>2023/6/14 Revision submitted<br>2023/6/14 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e1d2120964, createdName=lkjzlzq, createdTime=Tue Jul 11 16:07:53 CST 2023, time=2023-07-11, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2139663, encodeId=e74b2139663d4, content=偏重的研究方向:骨健康;蛋白质组<br>经验分享:投稿五天,现在处于With Supervising Editor状态,请问接收过的同行这个状态处于什么阶段,还有多久Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a4f2006670, createdName=湖, createdTime=Mon May 29 11:59:07 CST 2023, time=2023-05-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2089114, encodeId=0c3f20891145a, content=9月15日下午投的稿,晚上状态变成Under review,然后9月18日上午发现状态已经变成Awaiting EIC desicion,请问是要被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ceae5681716, createdName=ms7000000167420570, createdTime=Mon Sep 19 22:00:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248681, encodeId=2d161248681a2, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:衰老;细胞<br>经验分享:under review 多久一般,9.2号变成under后现在十天了,不知道是不是送外审了,之前没注意,一开始submitted然后with editor 就直接是under了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41e85416830, createdName=默默发文章的小东西, createdTime=Tue Sep 13 16:55:09 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913528, encodeId=4dee913528de, content=请问各位大神,12-14投稿,under review1周左右切换至 with supervising editor。各位的稿件最后都如何了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45442342972, createdName=12295554m76(暂无昵称), createdTime=Mon Jan 04 10:44:40 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117172, encodeId=2d4a211e172b3, content=各位大佬,投稿AGING CELL直接就With Supervising Editor,状态七天了,是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11e82202257, createdName=120b955dm62暂无昵称, createdTime=Thu Mar 02 09:28:22 CST 2023, time=2023-03-02, status=1, ipAttribution=浙江省)]
    2020-05-20 aipanda皮

    请问显示under review约一周后后变成了with supervising editor正常么
    艾特 188****3191(暂无昵称)

    23

    展开23条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=591350, encodeId=6cee591350b9, content=请问显示under review约一周后后变成了with supervising editor正常么 <br> 艾特 188****3191(暂无昵称), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd861997355, createdName=aipanda皮, createdTime=Wed May 20 23:08:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970070, encodeId=9d349e007046, content=投稿命中率:25.0<br>偏重的研究方向:细胞衰老<br>经验分享:投了一篇,7张大图,纯细胞研究。一审一个半月,4个审稿人,一堆问题,还需要补实验。修改用了三个月,中间还申请了一次延迟,补了不少实验。修回去之后,二审两个礼拜,直接接收。总体很nice,是一本非常认真的期刊,审稿人水平很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Tue Jun 01 14:36:26 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248213, encodeId=46f912482132d, content=7.1 投稿 <br>7.2-7.24 with editor in chief <br>7.25-8.4 under review <br>8.5-8.19 with supervising editor <br>8.20-9.5 under review <br>9.6-9.7 with supervising editor <br>9.8-至今 In review <br>已经两个多月了 ,想请教投过这个期刊上岸的大神,这后边还有什么步骤大概多久才能回来一审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=ms4000000851485808, createdTime=Fri Sep 09 21:44:11 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223567, encodeId=1624122356e85, content=偏重的研究方向:骨骼衰老<br>经验分享:投稿已经一周了,一直with editor in chief ,大家遇到过这种情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKHJoeMDwT8ic73jBc5wUdyQXpogRZA8D2ibh5gOicQ2Vs2xrKjGAdxic8jNfnNICEXZuUNeapibUJooNg/0, createdBy=76982150486, createdName=术士话剧, createdTime=Tue May 31 11:14:53 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147495, encodeId=4453214e49507, content=投稿命中率:25.0<br>经验分享:2022/10/31 投稿<br>2022/11/4 With supervising editor<br>2022/11/5 Under review<br>2022/11/14 In Review<br>2022/12/1 Decision:Major revision<br><br>2023/5/8 Revision submitted<br>2023/6/5 Decision: Minor revision<br><br>2023/6/14 Revision submitted<br>2023/6/14 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e1d2120964, createdName=lkjzlzq, createdTime=Tue Jul 11 16:07:53 CST 2023, time=2023-07-11, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2139663, encodeId=e74b2139663d4, content=偏重的研究方向:骨健康;蛋白质组<br>经验分享:投稿五天,现在处于With Supervising Editor状态,请问接收过的同行这个状态处于什么阶段,还有多久Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a4f2006670, createdName=湖, createdTime=Mon May 29 11:59:07 CST 2023, time=2023-05-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2089114, encodeId=0c3f20891145a, content=9月15日下午投的稿,晚上状态变成Under review,然后9月18日上午发现状态已经变成Awaiting EIC desicion,请问是要被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ceae5681716, createdName=ms7000000167420570, createdTime=Mon Sep 19 22:00:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248681, encodeId=2d161248681a2, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:衰老;细胞<br>经验分享:under review 多久一般,9.2号变成under后现在十天了,不知道是不是送外审了,之前没注意,一开始submitted然后with editor 就直接是under了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41e85416830, createdName=默默发文章的小东西, createdTime=Tue Sep 13 16:55:09 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913528, encodeId=4dee913528de, content=请问各位大神,12-14投稿,under review1周左右切换至 with supervising editor。各位的稿件最后都如何了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45442342972, createdName=12295554m76(暂无昵称), createdTime=Mon Jan 04 10:44:40 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117172, encodeId=2d4a211e172b3, content=各位大佬,投稿AGING CELL直接就With Supervising Editor,状态七天了,是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11e82202257, createdName=120b955dm62暂无昵称, createdTime=Thu Mar 02 09:28:22 CST 2023, time=2023-03-02, status=1, ipAttribution=浙江省)]
    2021-06-01 胡同串子羊

    投稿命中率:25.0
    偏重的研究方向:细胞衰老
    经验分享:投了一篇,7张大图,纯细胞研究。一审一个半月,4个审稿人,一堆问题,还需要补实验。修改用了三个月,中间还申请了一次延迟,补了不少实验。修回去之后,二审两个礼拜,直接接收。总体很nice,是一本非常认真的期刊,审稿人水平很高。

    14

    展开14条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=591350, encodeId=6cee591350b9, content=请问显示under review约一周后后变成了with supervising editor正常么 <br> 艾特 188****3191(暂无昵称), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd861997355, createdName=aipanda皮, createdTime=Wed May 20 23:08:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970070, encodeId=9d349e007046, content=投稿命中率:25.0<br>偏重的研究方向:细胞衰老<br>经验分享:投了一篇,7张大图,纯细胞研究。一审一个半月,4个审稿人,一堆问题,还需要补实验。修改用了三个月,中间还申请了一次延迟,补了不少实验。修回去之后,二审两个礼拜,直接接收。总体很nice,是一本非常认真的期刊,审稿人水平很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Tue Jun 01 14:36:26 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248213, encodeId=46f912482132d, content=7.1 投稿 <br>7.2-7.24 with editor in chief <br>7.25-8.4 under review <br>8.5-8.19 with supervising editor <br>8.20-9.5 under review <br>9.6-9.7 with supervising editor <br>9.8-至今 In review <br>已经两个多月了 ,想请教投过这个期刊上岸的大神,这后边还有什么步骤大概多久才能回来一审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=ms4000000851485808, createdTime=Fri Sep 09 21:44:11 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223567, encodeId=1624122356e85, content=偏重的研究方向:骨骼衰老<br>经验分享:投稿已经一周了,一直with editor in chief ,大家遇到过这种情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKHJoeMDwT8ic73jBc5wUdyQXpogRZA8D2ibh5gOicQ2Vs2xrKjGAdxic8jNfnNICEXZuUNeapibUJooNg/0, createdBy=76982150486, createdName=术士话剧, createdTime=Tue May 31 11:14:53 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147495, encodeId=4453214e49507, content=投稿命中率:25.0<br>经验分享:2022/10/31 投稿<br>2022/11/4 With supervising editor<br>2022/11/5 Under review<br>2022/11/14 In Review<br>2022/12/1 Decision:Major revision<br><br>2023/5/8 Revision submitted<br>2023/6/5 Decision: Minor revision<br><br>2023/6/14 Revision submitted<br>2023/6/14 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e1d2120964, createdName=lkjzlzq, createdTime=Tue Jul 11 16:07:53 CST 2023, time=2023-07-11, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2139663, encodeId=e74b2139663d4, content=偏重的研究方向:骨健康;蛋白质组<br>经验分享:投稿五天,现在处于With Supervising Editor状态,请问接收过的同行这个状态处于什么阶段,还有多久Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a4f2006670, createdName=湖, createdTime=Mon May 29 11:59:07 CST 2023, time=2023-05-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2089114, encodeId=0c3f20891145a, content=9月15日下午投的稿,晚上状态变成Under review,然后9月18日上午发现状态已经变成Awaiting EIC desicion,请问是要被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ceae5681716, createdName=ms7000000167420570, createdTime=Mon Sep 19 22:00:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248681, encodeId=2d161248681a2, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:衰老;细胞<br>经验分享:under review 多久一般,9.2号变成under后现在十天了,不知道是不是送外审了,之前没注意,一开始submitted然后with editor 就直接是under了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41e85416830, createdName=默默发文章的小东西, createdTime=Tue Sep 13 16:55:09 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913528, encodeId=4dee913528de, content=请问各位大神,12-14投稿,under review1周左右切换至 with supervising editor。各位的稿件最后都如何了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45442342972, createdName=12295554m76(暂无昵称), createdTime=Mon Jan 04 10:44:40 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117172, encodeId=2d4a211e172b3, content=各位大佬,投稿AGING CELL直接就With Supervising Editor,状态七天了,是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11e82202257, createdName=120b955dm62暂无昵称, createdTime=Thu Mar 02 09:28:22 CST 2023, time=2023-03-02, status=1, ipAttribution=浙江省)]
    2022-09-09 ms4000000851485808

    7.1 投稿
    7.2-7.24 with editor in chief
    7.25-8.4 under review
    8.5-8.19 with supervising editor
    8.20-9.5 under review
    9.6-9.7 with supervising editor
    9.8-至今 In review
    已经两个多月了 ,想请教投过这个期刊上岸的大神,这后边还有什么步骤大概多久才能回来一审意见

    10

    展开10条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=591350, encodeId=6cee591350b9, content=请问显示under review约一周后后变成了with supervising editor正常么 <br> 艾特 188****3191(暂无昵称), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd861997355, createdName=aipanda皮, createdTime=Wed May 20 23:08:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970070, encodeId=9d349e007046, content=投稿命中率:25.0<br>偏重的研究方向:细胞衰老<br>经验分享:投了一篇,7张大图,纯细胞研究。一审一个半月,4个审稿人,一堆问题,还需要补实验。修改用了三个月,中间还申请了一次延迟,补了不少实验。修回去之后,二审两个礼拜,直接接收。总体很nice,是一本非常认真的期刊,审稿人水平很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Tue Jun 01 14:36:26 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248213, encodeId=46f912482132d, content=7.1 投稿 <br>7.2-7.24 with editor in chief <br>7.25-8.4 under review <br>8.5-8.19 with supervising editor <br>8.20-9.5 under review <br>9.6-9.7 with supervising editor <br>9.8-至今 In review <br>已经两个多月了 ,想请教投过这个期刊上岸的大神,这后边还有什么步骤大概多久才能回来一审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=ms4000000851485808, createdTime=Fri Sep 09 21:44:11 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223567, encodeId=1624122356e85, content=偏重的研究方向:骨骼衰老<br>经验分享:投稿已经一周了,一直with editor in chief ,大家遇到过这种情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKHJoeMDwT8ic73jBc5wUdyQXpogRZA8D2ibh5gOicQ2Vs2xrKjGAdxic8jNfnNICEXZuUNeapibUJooNg/0, createdBy=76982150486, createdName=术士话剧, createdTime=Tue May 31 11:14:53 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147495, encodeId=4453214e49507, content=投稿命中率:25.0<br>经验分享:2022/10/31 投稿<br>2022/11/4 With supervising editor<br>2022/11/5 Under review<br>2022/11/14 In Review<br>2022/12/1 Decision:Major revision<br><br>2023/5/8 Revision submitted<br>2023/6/5 Decision: Minor revision<br><br>2023/6/14 Revision submitted<br>2023/6/14 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e1d2120964, createdName=lkjzlzq, createdTime=Tue Jul 11 16:07:53 CST 2023, time=2023-07-11, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2139663, encodeId=e74b2139663d4, content=偏重的研究方向:骨健康;蛋白质组<br>经验分享:投稿五天,现在处于With Supervising Editor状态,请问接收过的同行这个状态处于什么阶段,还有多久Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a4f2006670, createdName=湖, createdTime=Mon May 29 11:59:07 CST 2023, time=2023-05-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2089114, encodeId=0c3f20891145a, content=9月15日下午投的稿,晚上状态变成Under review,然后9月18日上午发现状态已经变成Awaiting EIC desicion,请问是要被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ceae5681716, createdName=ms7000000167420570, createdTime=Mon Sep 19 22:00:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248681, encodeId=2d161248681a2, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:衰老;细胞<br>经验分享:under review 多久一般,9.2号变成under后现在十天了,不知道是不是送外审了,之前没注意,一开始submitted然后with editor 就直接是under了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41e85416830, createdName=默默发文章的小东西, createdTime=Tue Sep 13 16:55:09 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913528, encodeId=4dee913528de, content=请问各位大神,12-14投稿,under review1周左右切换至 with supervising editor。各位的稿件最后都如何了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45442342972, createdName=12295554m76(暂无昵称), createdTime=Mon Jan 04 10:44:40 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117172, encodeId=2d4a211e172b3, content=各位大佬,投稿AGING CELL直接就With Supervising Editor,状态七天了,是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11e82202257, createdName=120b955dm62暂无昵称, createdTime=Thu Mar 02 09:28:22 CST 2023, time=2023-03-02, status=1, ipAttribution=浙江省)]
    2022-05-31 术士话剧

    偏重的研究方向:骨骼衰老
    经验分享:投稿已经一周了,一直with editor in chief ,大家遇到过这种情况吗?

    9

    展开9条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=591350, encodeId=6cee591350b9, content=请问显示under review约一周后后变成了with supervising editor正常么 <br> 艾特 188****3191(暂无昵称), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd861997355, createdName=aipanda皮, createdTime=Wed May 20 23:08:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970070, encodeId=9d349e007046, content=投稿命中率:25.0<br>偏重的研究方向:细胞衰老<br>经验分享:投了一篇,7张大图,纯细胞研究。一审一个半月,4个审稿人,一堆问题,还需要补实验。修改用了三个月,中间还申请了一次延迟,补了不少实验。修回去之后,二审两个礼拜,直接接收。总体很nice,是一本非常认真的期刊,审稿人水平很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Tue Jun 01 14:36:26 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248213, encodeId=46f912482132d, content=7.1 投稿 <br>7.2-7.24 with editor in chief <br>7.25-8.4 under review <br>8.5-8.19 with supervising editor <br>8.20-9.5 under review <br>9.6-9.7 with supervising editor <br>9.8-至今 In review <br>已经两个多月了 ,想请教投过这个期刊上岸的大神,这后边还有什么步骤大概多久才能回来一审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=ms4000000851485808, createdTime=Fri Sep 09 21:44:11 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223567, encodeId=1624122356e85, content=偏重的研究方向:骨骼衰老<br>经验分享:投稿已经一周了,一直with editor in chief ,大家遇到过这种情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKHJoeMDwT8ic73jBc5wUdyQXpogRZA8D2ibh5gOicQ2Vs2xrKjGAdxic8jNfnNICEXZuUNeapibUJooNg/0, createdBy=76982150486, createdName=术士话剧, createdTime=Tue May 31 11:14:53 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147495, encodeId=4453214e49507, content=投稿命中率:25.0<br>经验分享:2022/10/31 投稿<br>2022/11/4 With supervising editor<br>2022/11/5 Under review<br>2022/11/14 In Review<br>2022/12/1 Decision:Major revision<br><br>2023/5/8 Revision submitted<br>2023/6/5 Decision: Minor revision<br><br>2023/6/14 Revision submitted<br>2023/6/14 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e1d2120964, createdName=lkjzlzq, createdTime=Tue Jul 11 16:07:53 CST 2023, time=2023-07-11, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2139663, encodeId=e74b2139663d4, content=偏重的研究方向:骨健康;蛋白质组<br>经验分享:投稿五天,现在处于With Supervising Editor状态,请问接收过的同行这个状态处于什么阶段,还有多久Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a4f2006670, createdName=湖, createdTime=Mon May 29 11:59:07 CST 2023, time=2023-05-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2089114, encodeId=0c3f20891145a, content=9月15日下午投的稿,晚上状态变成Under review,然后9月18日上午发现状态已经变成Awaiting EIC desicion,请问是要被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ceae5681716, createdName=ms7000000167420570, createdTime=Mon Sep 19 22:00:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248681, encodeId=2d161248681a2, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:衰老;细胞<br>经验分享:under review 多久一般,9.2号变成under后现在十天了,不知道是不是送外审了,之前没注意,一开始submitted然后with editor 就直接是under了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41e85416830, createdName=默默发文章的小东西, createdTime=Tue Sep 13 16:55:09 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913528, encodeId=4dee913528de, content=请问各位大神,12-14投稿,under review1周左右切换至 with supervising editor。各位的稿件最后都如何了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45442342972, createdName=12295554m76(暂无昵称), createdTime=Mon Jan 04 10:44:40 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117172, encodeId=2d4a211e172b3, content=各位大佬,投稿AGING CELL直接就With Supervising Editor,状态七天了,是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11e82202257, createdName=120b955dm62暂无昵称, createdTime=Thu Mar 02 09:28:22 CST 2023, time=2023-03-02, status=1, ipAttribution=浙江省)]
    2023-07-11 lkjzlzq 来自云南省

    投稿命中率:25.0
    经验分享:2022/10/31 投稿
    2022/11/4 With supervising editor
    2022/11/5 Under review
    2022/11/14 In Review
    2022/12/1 Decision:Major revision

    2023/5/8 Revision submitted
    2023/6/5 Decision: Minor revision

    2023/6/14 Revision submitted
    2023/6/14 Accepted

    8

    展开8条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=591350, encodeId=6cee591350b9, content=请问显示under review约一周后后变成了with supervising editor正常么 <br> 艾特 188****3191(暂无昵称), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd861997355, createdName=aipanda皮, createdTime=Wed May 20 23:08:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970070, encodeId=9d349e007046, content=投稿命中率:25.0<br>偏重的研究方向:细胞衰老<br>经验分享:投了一篇,7张大图,纯细胞研究。一审一个半月,4个审稿人,一堆问题,还需要补实验。修改用了三个月,中间还申请了一次延迟,补了不少实验。修回去之后,二审两个礼拜,直接接收。总体很nice,是一本非常认真的期刊,审稿人水平很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Tue Jun 01 14:36:26 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248213, encodeId=46f912482132d, content=7.1 投稿 <br>7.2-7.24 with editor in chief <br>7.25-8.4 under review <br>8.5-8.19 with supervising editor <br>8.20-9.5 under review <br>9.6-9.7 with supervising editor <br>9.8-至今 In review <br>已经两个多月了 ,想请教投过这个期刊上岸的大神,这后边还有什么步骤大概多久才能回来一审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=ms4000000851485808, createdTime=Fri Sep 09 21:44:11 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223567, encodeId=1624122356e85, content=偏重的研究方向:骨骼衰老<br>经验分享:投稿已经一周了,一直with editor in chief ,大家遇到过这种情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKHJoeMDwT8ic73jBc5wUdyQXpogRZA8D2ibh5gOicQ2Vs2xrKjGAdxic8jNfnNICEXZuUNeapibUJooNg/0, createdBy=76982150486, createdName=术士话剧, createdTime=Tue May 31 11:14:53 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147495, encodeId=4453214e49507, content=投稿命中率:25.0<br>经验分享:2022/10/31 投稿<br>2022/11/4 With supervising editor<br>2022/11/5 Under review<br>2022/11/14 In Review<br>2022/12/1 Decision:Major revision<br><br>2023/5/8 Revision submitted<br>2023/6/5 Decision: Minor revision<br><br>2023/6/14 Revision submitted<br>2023/6/14 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e1d2120964, createdName=lkjzlzq, createdTime=Tue Jul 11 16:07:53 CST 2023, time=2023-07-11, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2139663, encodeId=e74b2139663d4, content=偏重的研究方向:骨健康;蛋白质组<br>经验分享:投稿五天,现在处于With Supervising Editor状态,请问接收过的同行这个状态处于什么阶段,还有多久Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a4f2006670, createdName=湖, createdTime=Mon May 29 11:59:07 CST 2023, time=2023-05-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2089114, encodeId=0c3f20891145a, content=9月15日下午投的稿,晚上状态变成Under review,然后9月18日上午发现状态已经变成Awaiting EIC desicion,请问是要被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ceae5681716, createdName=ms7000000167420570, createdTime=Mon Sep 19 22:00:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248681, encodeId=2d161248681a2, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:衰老;细胞<br>经验分享:under review 多久一般,9.2号变成under后现在十天了,不知道是不是送外审了,之前没注意,一开始submitted然后with editor 就直接是under了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41e85416830, createdName=默默发文章的小东西, createdTime=Tue Sep 13 16:55:09 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913528, encodeId=4dee913528de, content=请问各位大神,12-14投稿,under review1周左右切换至 with supervising editor。各位的稿件最后都如何了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45442342972, createdName=12295554m76(暂无昵称), createdTime=Mon Jan 04 10:44:40 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117172, encodeId=2d4a211e172b3, content=各位大佬,投稿AGING CELL直接就With Supervising Editor,状态七天了,是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11e82202257, createdName=120b955dm62暂无昵称, createdTime=Thu Mar 02 09:28:22 CST 2023, time=2023-03-02, status=1, ipAttribution=浙江省)]
    2023-05-29 来自广东省

    偏重的研究方向:骨健康;蛋白质组
    经验分享:投稿五天,现在处于With Supervising Editor状态,请问接收过的同行这个状态处于什么阶段,还有多久Under Review

    8

    展开8条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=591350, encodeId=6cee591350b9, content=请问显示under review约一周后后变成了with supervising editor正常么 <br> 艾特 188****3191(暂无昵称), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd861997355, createdName=aipanda皮, createdTime=Wed May 20 23:08:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970070, encodeId=9d349e007046, content=投稿命中率:25.0<br>偏重的研究方向:细胞衰老<br>经验分享:投了一篇,7张大图,纯细胞研究。一审一个半月,4个审稿人,一堆问题,还需要补实验。修改用了三个月,中间还申请了一次延迟,补了不少实验。修回去之后,二审两个礼拜,直接接收。总体很nice,是一本非常认真的期刊,审稿人水平很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Tue Jun 01 14:36:26 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248213, encodeId=46f912482132d, content=7.1 投稿 <br>7.2-7.24 with editor in chief <br>7.25-8.4 under review <br>8.5-8.19 with supervising editor <br>8.20-9.5 under review <br>9.6-9.7 with supervising editor <br>9.8-至今 In review <br>已经两个多月了 ,想请教投过这个期刊上岸的大神,这后边还有什么步骤大概多久才能回来一审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=ms4000000851485808, createdTime=Fri Sep 09 21:44:11 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223567, encodeId=1624122356e85, content=偏重的研究方向:骨骼衰老<br>经验分享:投稿已经一周了,一直with editor in chief ,大家遇到过这种情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKHJoeMDwT8ic73jBc5wUdyQXpogRZA8D2ibh5gOicQ2Vs2xrKjGAdxic8jNfnNICEXZuUNeapibUJooNg/0, createdBy=76982150486, createdName=术士话剧, createdTime=Tue May 31 11:14:53 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147495, encodeId=4453214e49507, content=投稿命中率:25.0<br>经验分享:2022/10/31 投稿<br>2022/11/4 With supervising editor<br>2022/11/5 Under review<br>2022/11/14 In Review<br>2022/12/1 Decision:Major revision<br><br>2023/5/8 Revision submitted<br>2023/6/5 Decision: Minor revision<br><br>2023/6/14 Revision submitted<br>2023/6/14 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e1d2120964, createdName=lkjzlzq, createdTime=Tue Jul 11 16:07:53 CST 2023, time=2023-07-11, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2139663, encodeId=e74b2139663d4, content=偏重的研究方向:骨健康;蛋白质组<br>经验分享:投稿五天,现在处于With Supervising Editor状态,请问接收过的同行这个状态处于什么阶段,还有多久Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a4f2006670, createdName=湖, createdTime=Mon May 29 11:59:07 CST 2023, time=2023-05-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2089114, encodeId=0c3f20891145a, content=9月15日下午投的稿,晚上状态变成Under review,然后9月18日上午发现状态已经变成Awaiting EIC desicion,请问是要被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ceae5681716, createdName=ms7000000167420570, createdTime=Mon Sep 19 22:00:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248681, encodeId=2d161248681a2, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:衰老;细胞<br>经验分享:under review 多久一般,9.2号变成under后现在十天了,不知道是不是送外审了,之前没注意,一开始submitted然后with editor 就直接是under了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41e85416830, createdName=默默发文章的小东西, createdTime=Tue Sep 13 16:55:09 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913528, encodeId=4dee913528de, content=请问各位大神,12-14投稿,under review1周左右切换至 with supervising editor。各位的稿件最后都如何了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45442342972, createdName=12295554m76(暂无昵称), createdTime=Mon Jan 04 10:44:40 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117172, encodeId=2d4a211e172b3, content=各位大佬,投稿AGING CELL直接就With Supervising Editor,状态七天了,是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11e82202257, createdName=120b955dm62暂无昵称, createdTime=Thu Mar 02 09:28:22 CST 2023, time=2023-03-02, status=1, ipAttribution=浙江省)]
    2022-09-19 ms7000000167420570

    9月15日下午投的稿,晚上状态变成Under review,然后9月18日上午发现状态已经变成Awaiting EIC desicion,请问是要被拒了吗

    7

    展开7条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=591350, encodeId=6cee591350b9, content=请问显示under review约一周后后变成了with supervising editor正常么 <br> 艾特 188****3191(暂无昵称), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd861997355, createdName=aipanda皮, createdTime=Wed May 20 23:08:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970070, encodeId=9d349e007046, content=投稿命中率:25.0<br>偏重的研究方向:细胞衰老<br>经验分享:投了一篇,7张大图,纯细胞研究。一审一个半月,4个审稿人,一堆问题,还需要补实验。修改用了三个月,中间还申请了一次延迟,补了不少实验。修回去之后,二审两个礼拜,直接接收。总体很nice,是一本非常认真的期刊,审稿人水平很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Tue Jun 01 14:36:26 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248213, encodeId=46f912482132d, content=7.1 投稿 <br>7.2-7.24 with editor in chief <br>7.25-8.4 under review <br>8.5-8.19 with supervising editor <br>8.20-9.5 under review <br>9.6-9.7 with supervising editor <br>9.8-至今 In review <br>已经两个多月了 ,想请教投过这个期刊上岸的大神,这后边还有什么步骤大概多久才能回来一审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=ms4000000851485808, createdTime=Fri Sep 09 21:44:11 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223567, encodeId=1624122356e85, content=偏重的研究方向:骨骼衰老<br>经验分享:投稿已经一周了,一直with editor in chief ,大家遇到过这种情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKHJoeMDwT8ic73jBc5wUdyQXpogRZA8D2ibh5gOicQ2Vs2xrKjGAdxic8jNfnNICEXZuUNeapibUJooNg/0, createdBy=76982150486, createdName=术士话剧, createdTime=Tue May 31 11:14:53 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147495, encodeId=4453214e49507, content=投稿命中率:25.0<br>经验分享:2022/10/31 投稿<br>2022/11/4 With supervising editor<br>2022/11/5 Under review<br>2022/11/14 In Review<br>2022/12/1 Decision:Major revision<br><br>2023/5/8 Revision submitted<br>2023/6/5 Decision: Minor revision<br><br>2023/6/14 Revision submitted<br>2023/6/14 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e1d2120964, createdName=lkjzlzq, createdTime=Tue Jul 11 16:07:53 CST 2023, time=2023-07-11, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2139663, encodeId=e74b2139663d4, content=偏重的研究方向:骨健康;蛋白质组<br>经验分享:投稿五天,现在处于With Supervising Editor状态,请问接收过的同行这个状态处于什么阶段,还有多久Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a4f2006670, createdName=湖, createdTime=Mon May 29 11:59:07 CST 2023, time=2023-05-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2089114, encodeId=0c3f20891145a, content=9月15日下午投的稿,晚上状态变成Under review,然后9月18日上午发现状态已经变成Awaiting EIC desicion,请问是要被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ceae5681716, createdName=ms7000000167420570, createdTime=Mon Sep 19 22:00:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248681, encodeId=2d161248681a2, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:衰老;细胞<br>经验分享:under review 多久一般,9.2号变成under后现在十天了,不知道是不是送外审了,之前没注意,一开始submitted然后with editor 就直接是under了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41e85416830, createdName=默默发文章的小东西, createdTime=Tue Sep 13 16:55:09 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913528, encodeId=4dee913528de, content=请问各位大神,12-14投稿,under review1周左右切换至 with supervising editor。各位的稿件最后都如何了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45442342972, createdName=12295554m76(暂无昵称), createdTime=Mon Jan 04 10:44:40 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117172, encodeId=2d4a211e172b3, content=各位大佬,投稿AGING CELL直接就With Supervising Editor,状态七天了,是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11e82202257, createdName=120b955dm62暂无昵称, createdTime=Thu Mar 02 09:28:22 CST 2023, time=2023-03-02, status=1, ipAttribution=浙江省)]
    2022-09-13 默默发文章的小东西

    审稿速度:6.0 | 投稿命中率:25.0
    偏重的研究方向:衰老;细胞
    经验分享:under review 多久一般,9.2号变成under后现在十天了,不知道是不是送外审了,之前没注意,一开始submitted然后with editor 就直接是under了

    6

    展开6条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=591350, encodeId=6cee591350b9, content=请问显示under review约一周后后变成了with supervising editor正常么 <br> 艾特 188****3191(暂无昵称), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd861997355, createdName=aipanda皮, createdTime=Wed May 20 23:08:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970070, encodeId=9d349e007046, content=投稿命中率:25.0<br>偏重的研究方向:细胞衰老<br>经验分享:投了一篇,7张大图,纯细胞研究。一审一个半月,4个审稿人,一堆问题,还需要补实验。修改用了三个月,中间还申请了一次延迟,补了不少实验。修回去之后,二审两个礼拜,直接接收。总体很nice,是一本非常认真的期刊,审稿人水平很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Tue Jun 01 14:36:26 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248213, encodeId=46f912482132d, content=7.1 投稿 <br>7.2-7.24 with editor in chief <br>7.25-8.4 under review <br>8.5-8.19 with supervising editor <br>8.20-9.5 under review <br>9.6-9.7 with supervising editor <br>9.8-至今 In review <br>已经两个多月了 ,想请教投过这个期刊上岸的大神,这后边还有什么步骤大概多久才能回来一审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=ms4000000851485808, createdTime=Fri Sep 09 21:44:11 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223567, encodeId=1624122356e85, content=偏重的研究方向:骨骼衰老<br>经验分享:投稿已经一周了,一直with editor in chief ,大家遇到过这种情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKHJoeMDwT8ic73jBc5wUdyQXpogRZA8D2ibh5gOicQ2Vs2xrKjGAdxic8jNfnNICEXZuUNeapibUJooNg/0, createdBy=76982150486, createdName=术士话剧, createdTime=Tue May 31 11:14:53 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147495, encodeId=4453214e49507, content=投稿命中率:25.0<br>经验分享:2022/10/31 投稿<br>2022/11/4 With supervising editor<br>2022/11/5 Under review<br>2022/11/14 In Review<br>2022/12/1 Decision:Major revision<br><br>2023/5/8 Revision submitted<br>2023/6/5 Decision: Minor revision<br><br>2023/6/14 Revision submitted<br>2023/6/14 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e1d2120964, createdName=lkjzlzq, createdTime=Tue Jul 11 16:07:53 CST 2023, time=2023-07-11, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2139663, encodeId=e74b2139663d4, content=偏重的研究方向:骨健康;蛋白质组<br>经验分享:投稿五天,现在处于With Supervising Editor状态,请问接收过的同行这个状态处于什么阶段,还有多久Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a4f2006670, createdName=湖, createdTime=Mon May 29 11:59:07 CST 2023, time=2023-05-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2089114, encodeId=0c3f20891145a, content=9月15日下午投的稿,晚上状态变成Under review,然后9月18日上午发现状态已经变成Awaiting EIC desicion,请问是要被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ceae5681716, createdName=ms7000000167420570, createdTime=Mon Sep 19 22:00:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248681, encodeId=2d161248681a2, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:衰老;细胞<br>经验分享:under review 多久一般,9.2号变成under后现在十天了,不知道是不是送外审了,之前没注意,一开始submitted然后with editor 就直接是under了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41e85416830, createdName=默默发文章的小东西, createdTime=Tue Sep 13 16:55:09 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913528, encodeId=4dee913528de, content=请问各位大神,12-14投稿,under review1周左右切换至 with supervising editor。各位的稿件最后都如何了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45442342972, createdName=12295554m76(暂无昵称), createdTime=Mon Jan 04 10:44:40 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117172, encodeId=2d4a211e172b3, content=各位大佬,投稿AGING CELL直接就With Supervising Editor,状态七天了,是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11e82202257, createdName=120b955dm62暂无昵称, createdTime=Thu Mar 02 09:28:22 CST 2023, time=2023-03-02, status=1, ipAttribution=浙江省)]
    2021-01-04 12295554m76(暂无昵称)

    请问各位大神,12-14投稿,under review1周左右切换至 with supervising editor。各位的稿件最后都如何了?

    6

    展开6条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=591350, encodeId=6cee591350b9, content=请问显示under review约一周后后变成了with supervising editor正常么 <br> 艾特 188****3191(暂无昵称), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd861997355, createdName=aipanda皮, createdTime=Wed May 20 23:08:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970070, encodeId=9d349e007046, content=投稿命中率:25.0<br>偏重的研究方向:细胞衰老<br>经验分享:投了一篇,7张大图,纯细胞研究。一审一个半月,4个审稿人,一堆问题,还需要补实验。修改用了三个月,中间还申请了一次延迟,补了不少实验。修回去之后,二审两个礼拜,直接接收。总体很nice,是一本非常认真的期刊,审稿人水平很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Tue Jun 01 14:36:26 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248213, encodeId=46f912482132d, content=7.1 投稿 <br>7.2-7.24 with editor in chief <br>7.25-8.4 under review <br>8.5-8.19 with supervising editor <br>8.20-9.5 under review <br>9.6-9.7 with supervising editor <br>9.8-至今 In review <br>已经两个多月了 ,想请教投过这个期刊上岸的大神,这后边还有什么步骤大概多久才能回来一审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=ms4000000851485808, createdTime=Fri Sep 09 21:44:11 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223567, encodeId=1624122356e85, content=偏重的研究方向:骨骼衰老<br>经验分享:投稿已经一周了,一直with editor in chief ,大家遇到过这种情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKHJoeMDwT8ic73jBc5wUdyQXpogRZA8D2ibh5gOicQ2Vs2xrKjGAdxic8jNfnNICEXZuUNeapibUJooNg/0, createdBy=76982150486, createdName=术士话剧, createdTime=Tue May 31 11:14:53 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147495, encodeId=4453214e49507, content=投稿命中率:25.0<br>经验分享:2022/10/31 投稿<br>2022/11/4 With supervising editor<br>2022/11/5 Under review<br>2022/11/14 In Review<br>2022/12/1 Decision:Major revision<br><br>2023/5/8 Revision submitted<br>2023/6/5 Decision: Minor revision<br><br>2023/6/14 Revision submitted<br>2023/6/14 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e1d2120964, createdName=lkjzlzq, createdTime=Tue Jul 11 16:07:53 CST 2023, time=2023-07-11, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2139663, encodeId=e74b2139663d4, content=偏重的研究方向:骨健康;蛋白质组<br>经验分享:投稿五天,现在处于With Supervising Editor状态,请问接收过的同行这个状态处于什么阶段,还有多久Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a4f2006670, createdName=湖, createdTime=Mon May 29 11:59:07 CST 2023, time=2023-05-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2089114, encodeId=0c3f20891145a, content=9月15日下午投的稿,晚上状态变成Under review,然后9月18日上午发现状态已经变成Awaiting EIC desicion,请问是要被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ceae5681716, createdName=ms7000000167420570, createdTime=Mon Sep 19 22:00:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248681, encodeId=2d161248681a2, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:衰老;细胞<br>经验分享:under review 多久一般,9.2号变成under后现在十天了,不知道是不是送外审了,之前没注意,一开始submitted然后with editor 就直接是under了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41e85416830, createdName=默默发文章的小东西, createdTime=Tue Sep 13 16:55:09 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913528, encodeId=4dee913528de, content=请问各位大神,12-14投稿,under review1周左右切换至 with supervising editor。各位的稿件最后都如何了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45442342972, createdName=12295554m76(暂无昵称), createdTime=Mon Jan 04 10:44:40 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117172, encodeId=2d4a211e172b3, content=各位大佬,投稿AGING CELL直接就With Supervising Editor,状态七天了,是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11e82202257, createdName=120b955dm62暂无昵称, createdTime=Thu Mar 02 09:28:22 CST 2023, time=2023-03-02, status=1, ipAttribution=浙江省)]
    2023-03-02 120b955dm62暂无昵称 来自浙江省

    各位大佬,投稿AGING CELL直接就With Supervising Editor,状态七天了,是不是要被拒了

    5

    展开5条回复
共170条页码: 1/17页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分